000			01290 a2200385 4500
005			20250517042607.0
264		0	_c20160329
008			201603s 0 0 eng d
022			_a2374-2445
024	7		_a10.1001/jamaoncol.2015.35 _2doi
040			_aNLM _beng _cNLM
100	1		_aHorlings, Hugo M
245	0	0	_aUsing Somatic Mutations to Guide Treatment Decisions: Context Matters. _h[electronic resource]
260			_bJAMA oncology _cJun 2015
300			_a275-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aHumans
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aMutation
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPatient Selection
650	0	4	_aPhenotype
650	0	4	_aPrecision Medicine
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
700	1		_aShah, Sohrab P
700	1		_aHuntsman, David G
773	0		_tJAMA oncology _gvol. 1 _gno. 3 _gp. 275-6
856	4	0	_uhttps://doi.org/10.1001/jamaoncol.2015.35 _zAvailable from publisher's website
999			_c25080492 _d25080492